TIBS Awarded The Best Biomedical Investment Institution 2023
Trinity Innovation Bioventure Singapore
A biomedical VC fund focusing on innovation investment with deep insight and experience on Asia markets
The 7th Healthcare Investment Excellence List 2023 was launched by HaoYue Capital on April 03, 2023. Trinity Innovation Fund (TIF) managed by TIBS was awarded the Best Biomedical Investment Institution.
Investment Excellence List first started in 2016 to award the outstanding investment institutions and individuals in healthcare industry of China, including biopharma, medical devices, IVD and precision medicine, healthcare services and digital health. The list is selected by combining the opinions of authoritative healthcare experts, top investors, professional media, along with return on investment, investment in different sectors and other objective data.
This has been the second time TIBS was awarded in the Healthcare Investment Excellence List. In 2022, we were the Best Healthcare Early-stage Investment Institution of the Year.
We are thankful and feel rewarding to be elected in this list. We will continue our focus on innovation to nurture great biomedical companies in the World.